-
Ehab B. replied to the topic "PM Problem Involving Pre-clinical Trial Results and Market Entry Deadlines" – 2 months, 4 weeks ago
For a Class III bioabsorbable stent, dissolution timing is the value proposition. It dissolving too quickly then it does not meet the customer needs or design input that was actually intended for the device. In this situation, the PM has… Read more»